BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$1.31
Tradestie Score
58
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+968.7%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.81
$1.02B - 67 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.39
$711.32M - 60 Compare
ESPR Esperion Therapeutics, Inc.
$3.17
$584.71M - 56 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$35.70
$543.32M - 58 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.13
$275.13M - 56 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.13
$237.15M 6.2 55 Compare
BIOA BioAge Labs, Inc. Common Stock
$23.76
$212.23M - 56 Compare
ATRA Atara Biotherapeutics, Inc
$10.51
$101.48M - 54 Compare
KPTI Karyopharm Therapeutics Inc.
$10.21
$53.85M - 53 Compare
KYNB KYNB
$7.24
- - 59 Compare

Data updated: Jun 28, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry